IM Cannabis (IMCC) Cash & Equivalents (2019 - 2026)

IM Cannabis' Cash & Equivalents history runs 8 years deep, the most recent figure standing at $732122.5 for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 21.73% year-over-year to $732122.5; the TTM figure through Mar 2026 stood at $732122.5 (up 21.73% YoY), while the FY2025 annual figure was $2.0 million, up 210.23% from the prior year.
• Cash & Equivalents was $732122.5 for Q1 2026 at IM Cannabis, down from $2.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $11.0 million in Q1 2022 to a low of $573039.7 in Q2 2025.
• Historically, Cash & Equivalents has averaged $3.0 million across 5 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents sank 83.64% in 2022, then jumped 216.54% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $1.8 million in 2022, then retreated by 26.19% to $1.3 million in 2023, then slumped by 53.61% to $617777.8 in 2024, then surged by 216.54% to $2.0 million in 2025, then plunged by 62.56% to $732122.5 in 2026.
• The last three Cash & Equivalents figures came in at $732122.5 (Q1 2026), $2.0 million (Q4 2025), and $858882.6 (Q3 2025), per Business Quant data.